Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,449 | N/A | N/A | N/A | N/A |
| Depreciation Amortization | 53 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 37 | N/A | N/A | N/A | N/A |
| Other Working Capital | -4,973 | N/A | N/A | N/A | N/A |
| Other Operating Activity | 1,229 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-11,103 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,103 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $11,103 | $N/A | $N/A | $N/A | $N/A |
| Net Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,103 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -11,103 | 0 | 0 | 0 | 0 |